Literature DB >> 18644646

PHES: one label, different goods?!

Karin Weissenborn.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18644646     DOI： 10.1016/j.jhep.2008.06.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  22 in total

1.  Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver.

Authors:  Radha K Dhiman; Roshan Kurmi; Kiran K Thumburu; Sunil H Venkataramarao; Ritesh Agarwal; Ajay Duseja; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2010-05-28       Impact factor: 3.199

2.  Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.

Authors:  Sunil Taneja; Radha K Dhiman; Amit Khatri; Sandeep Goyal; Kiran K Thumbru; Ritesh Agarwal; Ajay Duseja; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2012-12-16

3.  Abnormal baseline brain activity in patients with HBV-related cirrhosis without overt hepatic encephalopathy revealed by resting-state functional MRI.

Authors:  Xiao-Fei Lv; Min Ye; Lu-Jun Han; Xue-Lin Zhang; Pei-Qiang Cai; Gui-Hua Jiang; Ying-Wei Qiu; Shi-Jun Qiu; Yao-Pan Wu; Kai Liu; Zhen-Yin Liu; Pei-Hong Wu; Chuan-Miao Xie
Journal:  Metab Brain Dis       Date:  2013-07-09       Impact factor: 3.584

4.  Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.

Authors:  Andrés Duarte-Rojo; José Estradas; Roberto Hernández-Ramos; Sergio Ponce-de-León; Juan Córdoba; Aldo Torre
Journal:  Dig Dis Sci       Date:  2011-04-03       Impact factor: 3.199

Review 5.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

6.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

Review 7.  Minimal hepatic encephalopathy.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb

8.  Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study.

Authors:  Sahaj Rathi; Madhu Chopra; Gourdas Chouduri; Praveen Sharma; Kaushal Madan; Mohinish Chhabra; Ramesh R Rai; Anurag Govil; Asokananda Konar; Mahesh Goenka; Manoj Agarwal; Jayanta Mukherjee; Vinay Thorat; Sanjay Salunkhe; Philip Abraham; Aabha Nagral; Ajay Jhaveri; Naresh Bhat; Joy Varghese; Arun R S; Deevaguntla C Reddy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-10-15

9.  Brain-derived neurotrophic factor as a potential diagnostic marker in minimal hepatic encephalopathy.

Authors:  Agnieszka Stawicka; Magdalena Świderska; Justyna Zbrzeźniak; Natalia Sołowianowicz; Aleksandra Woszczenko; Robert Flisiak; Jerzy Jaroszewicz
Journal:  Clin Exp Hepatol       Date:  2021-02-02

10.  Anomalous gray matter structural networks in patients with hepatitis B virus-related cirrhosis without overt hepatic encephalopathy.

Authors:  Xiao-Fei Lv; Kai Liu; Ying-Wei Qiu; Pei-Qiang Cai; Jing Li; Gui-Hua Jiang; Yan-Jia Deng; Xue-Lin Zhang; Pei-Hong Wu; Chuan-Miao Xie; Ge Wen
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.